Ignite Creation Date:
2024-05-06 @ 2:36 PM
Last Modification Date:
2024-10-26 @ 1:34 PM
Study NCT ID:
NCT04375254
Status:
UNKNOWN
Last Update Posted:
2021-03-16
First Post:
2020-05-03
Brief Title:
Neuroscience-based Nomenclature NbN as a Teaching Tool
Sponsor:
Hebrew University of Jerusalem
Organization:
Hebrew University of Jerusalem
Study Overview
Official Title:
The Effect of the Use Of Neuroscience-based Nomenclature NbN In The Teaching Of Psychopharmacology on Medical Students Views Toward Psychiatry
Status:
UNKNOWN
Status Verified Date:
2021-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In recent decades medical student interest in a career in mental health appear to be in decline possibly due to the perception that the scientific foundation of psychiatry and psychopharmacology is weaker compared to other fields of medicine
In an effort to examine ways of improving the current nomenclature in Psychopharmacology in 2008 the nomenclature taskforce was initiated composed of representatives from five international organizations ECNP - European College of Neuropsychopharmacology ACNP - American College of Neuropsychopharmacology AsCNP - Asian College of Neuropsychopharmacology CINP - International College of Neuropsychopharmacology IUPHAR - International Union of Basic and Clinical Pharmacology2 The result of this effort is the Neuroscience based Nomenclature NbN - a pharmacologically driven nomenclature that focuses on reflecting current knowledge and on the understanding of the neural system being modified
this research is the first that examine whether putting greater emphasis on neuroscience in the teaching of psychotropics through the use of the new NbN terminology achieve the goal of improving medical students views on psychiatry
In an effort to examine ways of improving the current nomenclature in Psychopharmacology in 2008 the nomenclature taskforce was initiated composed of representatives from five international organizations ECNP - European College of Neuropsychopharmacology ACNP - American College of Neuropsychopharmacology AsCNP - Asian College of Neuropsychopharmacology CINP - International College of Neuropsychopharmacology IUPHAR - International Union of Basic and Clinical Pharmacology2 The result of this effort is the Neuroscience based Nomenclature NbN - a pharmacologically driven nomenclature that focuses on reflecting current knowledge and on the understanding of the neural system being modified
this research is the first that examine whether putting greater emphasis on neuroscience in the teaching of psychotropics through the use of the new NbN terminology achieve the goal of improving medical students views on psychiatry
Detailed Description:
In recent decades medical student interest in a career in mental health appear to be in decline1 There are multiple factors responsible for the apparent lack of interest in psychiatry one of them may be the perception that the scientific foundation of psychiatry and psychopharmacology is weaker compared to other fields of medicine
As the field of psychopharmacology evolves the terminology used to describe different classes of medication becomes increasingly convoluted at a time when the same agent is used for the treatment of several different disorders the nomenclature in use is indication-based and divided into classes that are disease based - such as Antidepressant Antipsychotic and Anxiolytics These classes in turn are divided into subclasses like Atypical or Second Generation - terms that give little information regarding the pharmacological properties of the medication itself
This discrepancy between the current naming of psychotropics and the way they are used in clinical practice is confusing to both the clinician and the patient - and since it fails to reflect on the current scientific knowledge may affect the way young medical professionals perceive the profession of psychiatry
In an effort to examine ways of improving the current nomenclature in Psychopharmacology in 2008 the nomenclature taskforce was initiated composed of representatives from five international organizations ECNP - European College of Neuropsychopharmacology ACNP - American College of Neuropsychopharmacology AsCNP - Asian College of Neuropsychopharmacology CINP - International College of Neuropsychopharmacology IUPHAR - International Union of Basic and Clinical Pharmacology2 The result of this effort is the Neuroscience based Nomenclature NbN - a pharmacologically driven nomenclature that focuses on reflecting current knowledge and on the understanding of the neural system being modified pharmacological domain and its modemechanism of action mode of action3 The NbN was widely accepted by both clinicians and leading psychiatric journals4 The need to revise the teaching methods of psychopharmacology was reviewed over the years with different strategies suggested5 To our knowledge this research is the first that examine whether putting greater emphasis on neuroscience in the teaching of psychotropics through the use of a new terminology achieve the goal of improving medical students views on psychiatry
As the field of psychopharmacology evolves the terminology used to describe different classes of medication becomes increasingly convoluted at a time when the same agent is used for the treatment of several different disorders the nomenclature in use is indication-based and divided into classes that are disease based - such as Antidepressant Antipsychotic and Anxiolytics These classes in turn are divided into subclasses like Atypical or Second Generation - terms that give little information regarding the pharmacological properties of the medication itself
This discrepancy between the current naming of psychotropics and the way they are used in clinical practice is confusing to both the clinician and the patient - and since it fails to reflect on the current scientific knowledge may affect the way young medical professionals perceive the profession of psychiatry
In an effort to examine ways of improving the current nomenclature in Psychopharmacology in 2008 the nomenclature taskforce was initiated composed of representatives from five international organizations ECNP - European College of Neuropsychopharmacology ACNP - American College of Neuropsychopharmacology AsCNP - Asian College of Neuropsychopharmacology CINP - International College of Neuropsychopharmacology IUPHAR - International Union of Basic and Clinical Pharmacology2 The result of this effort is the Neuroscience based Nomenclature NbN - a pharmacologically driven nomenclature that focuses on reflecting current knowledge and on the understanding of the neural system being modified pharmacological domain and its modemechanism of action mode of action3 The NbN was widely accepted by both clinicians and leading psychiatric journals4 The need to revise the teaching methods of psychopharmacology was reviewed over the years with different strategies suggested5 To our knowledge this research is the first that examine whether putting greater emphasis on neuroscience in the teaching of psychotropics through the use of a new terminology achieve the goal of improving medical students views on psychiatry
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None